Explore Inspira Technologies' strategic insights on U.S. tariffs, market positioning, and growth potential in the medical device sector for February 2025.
Inspira Technologies Oxy B.H.N. Ltd. announces over 95% success in preventing bloodstream infections. Key developments and regulatory compliance detailed in February 2025 Form 6-K.
Inspira Technologies Oxy B.H.N. Ltd.'s 6-K report reveals a strategic partnership with Zriha Medical to enhance production. Filed on Jan 17, 2025, highlighting growth and regulatory compliance.
Explore Inspira Technologies' January 2025 Form 6-K report detailing their VORTX™ blood oxygenation technology, regulatory compliance, and key management insights.
Inspira Technologies' Form 6-K reveals proactive production plans amid respiratory virus concerns in China. Key press release included, highlighting market adaptability and compliance.
Inspira Technologies Oxy B.H.N. Ltd. submits its 6-K report detailing plans for Arab Health Expo 2025, highlighting strategic marketing and compliance with SEC regulations.
Discover key insights from Inspira Technologies Oxy B.H.N. Ltd.'s 2024 AGM, including quorum details, approved items, and regulatory compliance in this essential 6-K filing.
Explore Inspira Technologies Oxy B.H.N. Ltd.'s financial report detailing a $3.2M private placement, share offerings, and strategic plans for growth. Key insights included.